COO equity awards at Alkermes (NASDAQ: ALKS) detailed in Form 4

Rhea-AI Filing Summary

Alkermes plc reported that Executive Vice President and Chief Operating Officer Jackson Blair Curtis received new equity awards. He was granted stock options for 94,900 shares at an exercise price of $0.00 per share and a restricted stock unit award covering 44,078 shares, both held directly.

The stock options vest and become exercisable in four equal annual installments starting on March 2, 2027. The restricted stock units each represent the right to receive one ordinary share and also vest in four equal annual installments beginning on March 2, 2027, tying a significant portion of his compensation to long-term company performance.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Jackson Blair Curtis

Role EVP, Chief Operating Officer

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (Right to Buy)	94,900	$0.00	--
Grant/Award	Restricted Stock Unit Award	44,078	$0.00	--

Holdings After Transaction: Employee Stock Option (Right to Buy) — 94,900 shares (Direct); Restricted Stock Unit Award — 44,078 shares (Direct)

Footnotes (1)

1. Shares underlying the stock option vest and become exercisable in four equal annual installments, commencing on 3/2/2027. Each restricted stock unit represents a contingent right to receive one ordinary share. Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 3/2/2027.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jackson Blair Curtis

(Last) (First) (Middle)

900 WINTER STREET

(Street)

WALTHAM MA 02451

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Alkermes plc. [ ALKS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$30.25	03/02/2026		A		94,900		(1)	03/02/2036	Ordinary Shares	94,900	$0	94,900	D
Restricted Stock Unit Award	(2)	03/02/2026		A		44,078		(3)	(3)	Ordinary Shares	44,078	$0	44,078	D

Explanation of Responses:

1. Shares underlying the stock option vest and become exercisable in four equal annual installments, commencing on 3/2/2027.

2. Each restricted stock unit represents a contingent right to receive one ordinary share.

3. Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 3/2/2027.

	/s/ Shantale Greenson, attorney-in-fact for Blair C. Jackson	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity awards did Alkermes (ALKS) grant to its COO Jackson Blair Curtis?

Alkermes granted its COO stock options for 94,900 shares and a restricted stock unit award for 44,078 shares. Both awards are held directly and represent long-term incentive compensation linked to the company’s ordinary shares and future share price performance.

How do the new stock options for the Alkermes (ALKS) COO vest?

The COO’s 94,900 stock options vest in four equal annual installments beginning on March 2, 2027. This schedule means 25% of the options become exercisable each year, encouraging multi-year retention and alignment with Alkermes’ longer-term operational and financial results.

What are the terms of the restricted stock units granted by Alkermes (ALKS)?

Each restricted stock unit represents a contingent right to receive one ordinary share of Alkermes. The 44,078-unit award vests in four equal annual installments starting March 2, 2027, creating a phased ownership opportunity tied to the executive’s continued service and company performance.

Does the Alkermes (ALKS) COO’s Form 4 show any stock sales or disposals?

The Form 4 reports only grant or award acquisitions, with no sales or disposals. Both reported transactions are coded as awards, increasing the COO’s potential future equity stake through options and restricted stock units subject to their respective vesting schedules.

Are the Alkermes (ALKS) COO’s new equity awards directly owned?

Yes. The Form 4 identifies the ownership of both the stock options and restricted stock units as direct. There are no footnotes indicating indirect holdings through entities or any disclaimer of beneficial ownership, so the awards are attributable directly to the COO.